These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7425574)

  • 21. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder.
    Mennini T; Bigini P; Ravizza T; Vezzani A; Calvaresi N; Tortarolo M; Bendotti C
    J Neurosci Res; 2002 Nov; 70(4):553-60. PubMed ID: 12404509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quality of the early motor repertoire in preterm infants predicts minor neurologic dysfunction at school age.
    Bruggink JL; Einspieler C; Butcher PR; Van Braeckel KN; Prechtl HF; Bos AF
    J Pediatr; 2008 Jul; 153(1):32-9. PubMed ID: 18571531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease.
    Mandrioli J; Del Rio D; Zini A; Nichelli P; Merelli E; Beltrami D; Cesari C; Pellegrini N; Brighenti F; Sola P
    Neurosci Lett; 2006 Jul; 401(3):203-8. PubMed ID: 16600498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic change of proximal conduction in demyelinating neuropathies: a cervical magnetic stimulation combined with maximum voluntary contraction.
    Hitomi T; Kaji R; Murase N; Kohara N; Mezaki T; Nodera H; Kawamura T; Ikeda A; Shibasaki H
    Clin Neurophysiol; 2007 Apr; 118(4):741-50. PubMed ID: 17317300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial motor neuron diseases.
    Emery AE; Holloway S
    Adv Neurol; 1982; 36():139-47. PubMed ID: 7180680
    [No Abstract]   [Full Text] [Related]  

  • 26. Elevated levels of transcripts encoding a human retroviral envelope protein (syncytin) in muscles from patients with motor neuron disease.
    Oluwole SO; Yao Y; Conradi S; Kristensson K; Karlsson H
    Amyotroph Lateral Scler; 2007 Apr; 8(2):67-72. PubMed ID: 17453631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975 - 2004.
    Day TG; Scott M; Perring R; Doyle P
    Amyotroph Lateral Scler; 2007 Dec; 8(6):337-42. PubMed ID: 18033591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reorganisation of motor units in different motor neuron disorders.
    Emeryk-Szajewska B; Kopeć J; Karwańska A
    Electromyogr Clin Neurophysiol; 2003; 43(1):23-31. PubMed ID: 12613137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle morphometry in motor neuron disease.
    Froes MM; Kristmundsdottir F; Mahon M; Cumming WJ
    Neuropathol Appl Neurobiol; 1987; 13(6):405-19. PubMed ID: 3447070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inclusion body myopathy associated with motor neuron syndrome: three case reports.
    Cafforio G; Pistolesi S; D'Avino C; Galluzzi F; Patricelli A; Solito B; Fontanini G; Siciliano G
    Clin Neuropathol; 2005; 24(1):36-41. PubMed ID: 15696783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconsiderations about the abnormalities of somatosensory evoked potentials in motor neuron disease.
    Zakrzewska-Pniewska B; Gasik R; Kostera-Pruszczyk A; Emeryk-Szajewska B
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):107-12. PubMed ID: 10207680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.
    Ishiyama T; Okada R; Nishibe H; Mitsumoto H; Nakayama C
    Brain Res; 2004 Sep; 1019(1-2):226-36. PubMed ID: 15306257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free amino acid concentrations in spinal tissue from patients dying of motor neuron disease.
    Patten BM; Kurlander HM; Evans B
    Acta Neurol Scand; 1982 Nov; 66(5):594-9. PubMed ID: 7148401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease.
    Le Ber I; Camuzat A; Berger E; Hannequin D; Laquerrière A; Golfier V; Seilhean D; Viennet G; Couratier P; Verpillat P; Heath S; Camu W; Martinaud O; Lacomblez L; Vercelletto M; Salachas F; Sellal F; Didic M; Thomas-Anterion C; Puel M; Michel BF; Besse C; Duyckaerts C; Meininger V; Campion D; Dubois B; Brice A;
    Neurology; 2009 May; 72(19):1669-76. PubMed ID: 19433740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002).
    Zoing MC; Burke D; Pamphlett R; Kiernan MC
    J Clin Neurosci; 2006 Jan; 13(1):78-83. PubMed ID: 16410201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced EMG techniques in diagnostics of spinal muscular atrophies and motor neuron disease--magnetic stimulation, single fiber EMG and macro EMG.
    Bartousek J; Hlustík P; Grenarová O; Beranová M
    Acta Univ Palacki Olomuc Fac Med; 1993; 136():37-9. PubMed ID: 7887198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor neuron syndromes in cancer patients.
    Forsyth PA; Dalmau J; Graus F; Cwik V; Rosenblum MK; Posner JB
    Ann Neurol; 1997 Jun; 41(6):722-30. PubMed ID: 9189033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid nitrite and malondialdehyde levels in patients with motor neuron disease.
    Shukla R; Rajani M; Barthwal MK; Srivastava N; Dikshit M
    Int J Neurosci; 2003 Aug; 113(8):1043-54. PubMed ID: 12888419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the muscle pathology in motor neuron disease.
    Takenaka M; Konishi S; Masui Y
    Bull Osaka Med Sch; 1984 Jul; 30(1):56-66. PubMed ID: 6544605
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study.
    Leigh PN; Dodson A; Swash M; Brion JP; Anderton BH
    Brain; 1989 Apr; 112 ( Pt 2)():521-35. PubMed ID: 2706443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.